相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advances in understanding and management of retinopathy of prematurity
Mary Elizabeth Hartnett
SURVEY OF OPHTHALMOLOGY (2017)
Electroretinographic Responses in the Smallest Eyes
M. Elizabeth Hartnett
JAMA OPHTHALMOLOGY (2017)
Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity A Phase 1 Dosing Study
David K. Wallace et al.
JAMA OPHTHALMOLOGY (2017)
Reduction of Rod and Cone Function in 6.5-Year-Old Children Born Extremely Preterm
Anna E. C. Molnar et al.
JAMA OPHTHALMOLOGY (2017)
The Epidemiology of Retinopathy of Prematurity in the United States
Cassie A. Ludwig et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2017)
Reactivation of Retinopathy of Prematurity Three Years After Treatment With Bevacizumab
Amir R. Hajrasouliha et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2017)
Epidemiology of blindness in children
Ameenat Lola Solebo et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2017)
Erythropoietin Attenuates the Memory Deficits in Aging Rats by Rescuing the Oxidative Stress and Inflammation and Promoting BDNF Releasing
Zhankui Jia et al.
MOLECULAR NEUROBIOLOGY (2016)
Revisiting the role of erythropoietin for treatment of ocular disorders
S. L. Shirley Ding et al.
EYE (2016)
SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER BEVACIZUMAB OR RANIBIZUMAB TREATMENT FOR RETINOPATHY OF PREMATURITY
Wei-Chi Wu et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2016)
Neuronal Cell Death in the Inner Retina and the Influence of Vascular Endothelial Growth Factor Inhibition in a Diabetic Rat Model
Hae-Young Lopilly Park et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Quantitative Analyses of Retinal Vascular Area and Density After Different Methods to Reduce VEGF in a Rat Model of Retinopathy of Prematurity
Haibo Wang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Targeting Muller Cell-Derived VEGF164 to Reduce Intravitreal Neovascularization in the Rat Model of Retinopathy of Prematurity
Yanchao Jiang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Short Hairpin RNA-Mediated Knockdown of VEGFA in Muller Cells Reduces Intravitreal Neovascularization in a Rat Model of Retinopathy of Prematurity
Haibo Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Anti-VEGF Antibody Leads to Later Atypical Intravitreous Neovascularization and Activation of Angiogenic Pathways in a Rat Model of Retinopathy of Prematurity
Manabu McCloskey et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
VEGF-Mediated STAT3 Activation Inhibits Retinal Vascularization by Down-Regulating Local Erythropoietin Expression
Haibo Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Endogenous Erythropoietin Protects Neuroretinal Function in Ischemic Retinopathy
Freya M. Mowat et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Reactivation of Retinopathy of Prematurity After Bevacizumab Injection
Jennifer Hu et al.
ARCHIVES OF OPHTHALMOLOGY (2012)
Efficacy of Intravitreal Bevacizumab for Stage 3+Retinopathy of Prematurity.
Helen A. Mintz-Hittner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The HIV-1 Rev/RRE system is required for HIV-1 5′ UTR cis elements to augment encapsidation of heterologous RNA into HIV-1 viral particles
Adam S. Cockrell et al.
RETROVIROLOGY (2011)
Role of VEGF in organogenesis
Jody J. Haigh
Organogenesis (2010)
Muller cell-derived VEGF is a significant contributor to retinal neovascularization
Yanyan Bai et al.
JOURNAL OF PATHOLOGY (2009)
Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Muller Cells and Photoreceptors
Magali Saint-Geniez et al.
PLOS ONE (2008)
Vascular endothelial growth factor in eye disease
J. S. Penn et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2008)
Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury
Kazuaki Nishijima et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Pegaptanib for neovascular age-related macular degeneration
ES Gragoudas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization
S Ishida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
分享论文
